Clinical Trials Browser

Phase 2 × Completed × Naltrexone × Clear all

NCT04499950 2025-03-06

A-NEW

Phase 2 Completed

53 enrolled 14 charts

Breast Neoplasms, Obesity, Overweight

NCT01303835 2015-07-17

Low Dose Naltrexone for Glioma Patients

Phase 2 Completed

110 enrolled 9 charts

Glioblastoma, Glioma